AssuredPartners Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
AssuredPartners Investment Advisors's ELV Position: Q1 2026 in Review
AssuredPartners Investment Advisors increased its Elevance Health (ELV) stake by 6.8% in Q1 2026, buying an estimated $15.4K and bringing the position to 742 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #365.
AssuredPartners Investment Advisors first reported a position in ELV in Q4 2024 and has held it in 4 quarters since. The position peaked at $483K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- AssuredPartners Investment Advisors held 742 shares of Elevance Health worth $225K as of Q1 2026.
- AssuredPartners Investment Advisors bought 47 Elevance Health shares in Q1 2026, an estimated $15.4K.
- Elevance Health made up 0.02% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #365 holding.
- AssuredPartners Investment Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 4 quarters since.
- AssuredPartners Investment Advisors's Elevance Health position peaked at $483K in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.